{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:24:38Z","timestamp":1793147078196,"version":"4.5.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1001\/jamacardio.2021.4585","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:27:52Z","timestamp":1636590472000},"page":"130","source":"Crossref","is-referenced-by-count":51,"title":["Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction"],"prefix":"10.1001","volume":"7","author":[{"given":"Alexander T.","family":"Sandhu","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California"},{"name":"Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu P.","family":"Turakhia","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California"},{"name":"Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"},{"name":"Center for Digital Health, Stanford University, Stanford, California"},{"name":"Associate Editor, JAMA Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldrin F.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California"},{"name":"Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"hoi210074r1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association.","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"hoi210074r2","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/jamacardio.2019.3593","article-title":"Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86?000 individuals.","volume":"4","author":"Conrad","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"1","key":"hoi210074r3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ejhf.v23.1","article-title":"National trends in heart failure mortality in men and women, United Kingdom, 2000-2017.","volume":"23","author":"Taylor","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"hoi210074r4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.","volume":"168","author":"Cheng","year":"2014","journal-title":"Am Heart J"},{"issue":"4","key":"hoi210074r5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0735-1097(03)00789-7","article-title":"The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.","volume":"42","author":"Curtis","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"hoi210074r6","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/eurheartj\/ehy005","article-title":"Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.","volume":"39","author":"Lam","year":"2018","journal-title":"Eur Heart J"},{"issue":"24","key":"hoi210074r7","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"hoi210074r8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamacardio.2020.0898","article-title":"Association of optimal implementation of sodium-glucose cotransporter 2 inhibitor therapy with outcome for patients with heart failure.","volume":"5","author":"Bassi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"hoi210074r9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis.","volume":"10","author":"Burnett","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"4","key":"hoi210074r10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry.","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi210074r11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jchf.2016.12.018","article-title":"Early adoption of sacubitril\/valsartan for patients with heart failure with reduced ejection fraction: insights from Get With the Guidelines-Heart Failure (GWTG-HF).","volume":"5","author":"Luo","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"4","key":"hoi210074r12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/phar.2018.38.issue-4","article-title":"Guideline-directed medical therapy and survival following hospitalization in patients with heart failure.","volume":"38","author":"Tran","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"16","key":"hoi210074r13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015042","article-title":"Real-world analysis of guideline-based therapy after hospitalization for heart failure.","volume":"9","author":"Wirtz","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"hoi210074r14","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1001\/jamainternmed.2019.2788","article-title":"Association between dual use of Department of Veterans Affairs and Medicare Part D drug benefits and potentially unsafe prescribing.","volume":"179","author":"Thorpe","year":"2019","journal-title":"JAMA Intern Med"},{"key":"hoi210074r15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbi.2017.01.017","article-title":"Extraction of left ventricular ejection fraction information from various types of clinical reports.","volume":"67","author":"Kim","year":"2017","journal-title":"J Biomed Inform"},{"issue":"1","key":"hoi210074r16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12872-017-0580-8","article-title":"Unlocking echocardiogram measurements for heart disease research through natural language processing.","volume":"17","author":"Patterson","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"hoi210074r17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/106286060401900504","article-title":"Identifying hypertension-related comorbidities from administrative data: what\u2019s the optimal approach?","volume":"19","author":"Borzecki","year":"2004","journal-title":"Am J Med Qual"},{"issue":"7","key":"hoi210074r18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/jgs.2004.52.issue-7","article-title":"Anticoagulant use for atrial fibrillation in the elderly.","volume":"52","author":"Brophy","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"hoi210074r19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi210074r20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","article-title":"2021 update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee.","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi210074r21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.7326\/M17-0767","article-title":"Concentration of potentially preventable spending among high-cost Medicare subpopulations: an observational study.","volume":"167","author":"Figueroa","year":"2017","journal-title":"Ann Intern Med"},{"issue":"24","key":"hoi210074r22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016502","article-title":"Association of diagnostic coding-based frailty and outcomes in patients with heart failure: a report from the Veterans Affairs Health System.","volume":"9","author":"Kohsaka","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"hoi210074r23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jech.2004.029454","article-title":"A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena.","volume":"60","author":"Merlo","year":"2006","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"hoi210074r24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"5","key":"hoi210074r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002805","article-title":"Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: a cohort study of 93,000 UK patients.","volume":"16","author":"Conrad","year":"2019","journal-title":"PLoS Med"},{"issue":"11","key":"hoi210074r26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ejhf.2017.19.issue-11","article-title":"The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets.","volume":"19","author":"Zaman","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"hoi210074r28","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/archinte.159.16.1939","article-title":"Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.","volume":"159","author":"Gattis","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"hoi210074r29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ejheart.2004.09.009","article-title":"Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents.","volume":"7","author":"Jain","year":"2005","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"hoi210074r30","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.2146\/ajhp120267","article-title":"Implementation of a pharmacist-managed heart failure medication titration clinic.","volume":"70","author":"Martinez","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"hoi210074r31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009889.pub2","article-title":"Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.","author":"Driscoll","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"hoi210074r33","doi-asserted-by":"publisher","first-page":"l223","DOI":"10.1136\/bmj.l223","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study.","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"issue":"5","key":"hoi210074r34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cardfail.2008.01.014","article-title":"A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic.","volume":"14","author":"Goode","year":"2008","journal-title":"J Card Fail"},{"issue":"4","key":"hoi210074r35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/hrt.2006.089656","article-title":"Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure.","volume":"93","author":"Raphael","year":"2007","journal-title":"Heart"},{"issue":"8","key":"hoi210074r36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003430","article-title":"Health-related quality of life outcomes in PARADIGM-HF.","volume":"10","author":"Lewis","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"20","key":"hoi210074r37","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review.","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"hoi210074r38","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"issue":"21","key":"hoi210074r39","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.jacc.2020.07.023","article-title":"2020 ACC\/AHA clinical performance and quality measures for adults with heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures.","volume":"76","author":"Heidenreich","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"hoi210074r27","unstructured":"US Department of Veterans Affairs. 2021 VA health care copay rates. Accessed 13 May, 2021. https:\/\/www.va.gov\/health-care\/copay-rates\/"},{"key":"hoi210074r32","unstructured":"Pharmacy Benefits? VA. Management Services. Sacubitril and valsartan (ENTRESTO) criteria for use. September 2015. Accessed October 5, 2021. https:\/\/cardiacos.net\/wp-content\/uploads\/ArticulosMedicos\/20160924\/2015-ENTRESTO_Criteria_for_Use.pdf"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2785890\/jamacardiology_sandhu_2021_oi_210074_1655488945.93323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T15:00:52Z","timestamp":1655910052000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2785890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2021.4585","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}